Notch1 serves as a prognostic factor and regulates metastasis via regulating EGFR expression in hypopharyngeal squamous cell carcinoma

Objective Hypopharyngeal squamous cell carcinoma (HSCC) remains one of the most lethal malignancies in head and neck. Notch1 has been validated to play prominent roles in the occurrence and development of various types of cancer. The aim of this study was to explore the function and underlying mechanism of Notch1 in HSCC. Patients and methods Seventy-one cancer tissue samples and adjacent noncancerous formalin-fixed paraffin embedded tissue specimens were analyzed by immunohistochemistry. As Notch1 is overexpressed in HSCC, we further questioned whether there was a relationship between Notch1 and the clinicopathological characteristics. After confirming the successful knockdown of Notch1 by siRNA, the migration and invasion after gene knockdown were investigated by Transwell chambers. We then tried to identify YBX1 and EGFR expression using real-time PCR (RT-PCR) and Western blot analyses. To further determine whether the downexpression of EGFR was caused by YBX1 and the overexpression of YBX1 was caused by gene amplification, the expression of EGFR was detected by RT-PCR and Western blot assays. Results We found that the expression of Notch1 and EGFR in HSCC tissues was upregulated compared with those in the adjacent noncancerous tissues. Further clinicopathological characteristics analysis revealed that the expression of Notch1 was positively correlated with distant metastasis (P=0.003) and tumor differentiation (P=0.031). The high expression of Notch1 is an independent prognostic factor for a poor overall survival in patients with HSCC (P=0.015, χ2=10.403). Knocking down of Notch1 significantly inhibits the migration and invasion of FaDu cells in vitro. Mechanistic investigation reveals that Notch1 knockdown is found suppressing the expression of EGFR at transcriptional level. Interestingly, we further found that Notch1 knockdown also decreased the expression of YBX1, which is a transcription factor of EGFR. Moreover, the upregulation of YBX1 reverses the suppression of Notch1 on EGFR. Furthermore, forced overexpression of YBX1 induced the invasion of FaDu cells. Conclusion Taken together, we found a positively cross-linked role of Notch1 signaling in the outcome of HSCC, providing a novel valuable prognostic marker and potential therapeutic target for the treatment of HSCC patients. Notch1 is a core signaling molecule for regulating migration and invasion via interplaying with EGFR in HSCC cells.

[1]  Hua Zhou,et al.  Notch1 is a prognostic factor that is distinctly activated in the classical and proneural subtype of glioblastoma and that promotes glioma cell survival via the NF-κB(p65) pathway , 2018, Cell Death & Disease.

[2]  Rui-huan Gan,et al.  Notch1 regulates tongue cancer cells proliferation, apoptosis and invasion , 2018, Cell cycle.

[3]  Y. Zhen,et al.  The recombinant EGFR/CD13 bi-targeted fusion protein induces apoptosis and blocks tube formation. , 2017, Oncology reports.

[4]  Lei Wang,et al.  Overexpression of CXCR4 promotes invasion and migration of non-small cell lung cancer via EGFR and MMP-9. , 2017, Oncology letters.

[5]  L. Pang,et al.  The expression profile and clinicopathological significance of Notch1 in patients with colorectal cancer: a meta-analysis. , 2017, Future oncology.

[6]  Jian Hu,et al.  The Notch signaling pathway in head and neck squamous cell carcinoma: A meta-analysis. , 2017, Advances in clinical and experimental medicine : official organ Wroclaw Medical University.

[7]  Arndt F. Siekmann,et al.  Endothelial Notch signalling limits angiogenesis via control of artery formation , 2017, Nature Cell Biology.

[8]  Chuan Chen,et al.  Prognostic roles of Notch receptor mRNA expression in human ovarian cancer , 2017, Oncotarget.

[9]  N. Myong.  Altered expressions of Notch-1 signaling proteins and beta-catenin in progression of carcinoma in situ into squamous carcinoma of uterine cervix , 2017, Indian journal of pathology & microbiology.

[10]  Q. Sun,et al.  NOTCH1 is a poor prognostic factor for breast cancer and is associated with breast cancer stem cells , 2016, OncoTargets and therapy.

[11]  J. Shieh,et al.  Epidermal growth factor-induced ANGPTL4 enhances anoikis resistance and tumour metastasis in head and neck squamous cell carcinoma , 2016, Oncogene.

[12]  A. Kulkarni,et al.  NOTCH1 inhibition enhances the efficacy of conventional chemotherapeutic agents by targeting head neck cancer stem cell , 2016, Scientific Reports.

[13]  Y. Ko,et al.  Somatic Mutations and Genetic Variants of NOTCH1 in Head and Neck Squamous Cell Carcinoma Occurrence and Development , 2016, Scientific Reports.

[14]  C. Combescure,et al.  The prognostic value of expression of HIF1α, EGFR and VEGF-A, in localized prostate cancer for intermediate- and high-risk patients treated with radiation therapy with or without androgen deprivation therapy , 2012, Radiation oncology.

[15]  R. Gibbs,et al.  Exome Sequencing of Head and Neck Squamous Cell Carcinoma Reveals Inactivating Mutations in NOTCH1 , 2011, Science.

[16]  Daniel B. Neill,et al.  Inhibition of EGFR-STAT3 Signaling with Erlotinib Prevents Carcinogenesis in a Chemically-Induced Mouse Model of Oral Squamous Cell Carcinoma , 2010, Cancer Prevention Research.

[17]  Ling Yin,et al.  Notch signaling: emerging molecular targets for cancer therapy. , 2010, Biochemical pharmacology.

[18]  Jae Ho Lee,et al.  Protein overexpression and gene amplification of epidermal growth factor receptor in nonsmall cell lung carcinomas: Comparison of four commercially available antibodies by immunohistochemistry and fluorescence in situ hybridization study. , 2010, Lung cancer.

[19]  Hui Gao,et al.  Upregulation of Notch pathway molecules in oral squamous cell carcinoma. , 2010, International journal of oncology.

[20]  Q. Su,et al.  Notch-1 regulates transcription of the epidermal growth factor receptor through p53. , 2008, Carcinogenesis.

[21]  U. Lendahl,et al.  Notch signaling mediates hypoxia-induced tumor cell migration and invasion , 2008, Proceedings of the National Academy of Sciences.

[22]  A. Karsan,et al.  Jagged1-mediated Notch activation induces epithelial-to-mesenchymal transition through Slug-induced repression of E-cadherin. , 2007, The Journal of experimental medicine.

[23]  Zhiwei Wang,et al.  Down-regulation of notch-1 inhibits invasion by inactivation of nuclear factor-kappaB, vascular endothelial growth factor, and matrix metalloproteinase-9 in pancreatic cancer cells. , 2006, Cancer research.

[24]  A. Harris,et al.  Notch signaling from tumor cells: a new mechanism of angiogenesis. , 2005, Cancer cell.

[25]  G. Nolan,et al.  Y-box-binding protein 1 confers EGF independence to human mammary epithelial cells , 2005, Oncogene.

[26]  R. Klein,et al.  Notch activation induces apoptosis in neural progenitor cells through a p53-dependent pathway. , 2004, Developmental biology.

[27]  R. Hruban,et al.  Notch mediates TGF alpha-induced changes in epithelial differentiation during pancreatic tumorigenesis. , 2003, Cancer cell.

[28]  S. Ishii,et al.  Two human genes isolated by a novel method encode DNA-binding proteins containing a common region of homology. , 1988, Gene.

[29]  Yu-Jie Liang,et al.  Activation of Notch signaling in human tongue carcinoma. , 2011, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[30]  J. Rich,et al.  Receptor channel TRPC6 is a key mediator of Notch-driven glioblastoma growth and invasiveness. , 2010, Cancer research.